Zantac Returns to Shelves with a Different Formula

Monday, July 12, 2021

Zantac Returns to Shelves with a Different Formula

Written by Malman Law, reviewed by Steve J. Malman.

Even though Sanofi is facing many lawsuits over Zantac injuries, the company has re-released the product with an entirely new formula. These new sales should not impact litigation, and any victims should call a Chicago Zantac lawyer. 

In 2020, the Food and Drug Administration (FDA) issued a recall of all packages of Zantac and ranitidine products from all stores and distributors across the United States. This major recall resulted from research that linked the use of ranitidine-based heartburn medications to a higher risk of developing different types of cancer. 

As a result, many patients who received a cancer diagnosis after taking Zantac have filed lawsuits against Sanofi, the drug manufacturer. As Sanofi scrambles to try to avoid liability for causing life-threatening illnesses, it also has profits as its priority, as the company has re-released Zantac with a “new formula.”

If you are dealing with cancer or have lost a loved one to cancer, and you believe it might be connected with your Zantac use, it is important to discuss the matter with a Chicago Zantac lawyer right away. Do not let the new boxes of Zantac on the shelves deter you from taking legal action. 

The “New” Zantac

The new Zantac 360 boxes include the phrases “new formula” and “now with famotidine.” These can lead consumers to believe they are taking the same drug with a few changes when, in reality, the new Zantac is a completely different drug altogether. 

While completely different ingredients, both ranitidine and famotidine are H2 blockers, which both work to stop heartburn, GERD, acid reflux, and other related conditions. However, there is one major difference – ranitidine contained a chemical that was a carcinogen, while famotidine has no known cancer risks. This means that the new Zantac product is safer for consumers to use from what we know right now. 

The Lawsuits Will Not Stop Due to the Product Changes

Seeing boxes of Zantac lining the shelves again can be confusing for consumers, especially if you are now fighting cancer due to taking ranitidine-based Zantac. It might make some people wonder whether the Zantac legal cases are over since Sanofi is allowed to sell the product again. The marketing is very similar to the original product, and seeing sales of these boxes might make some people think they no longer have legal rights. 

It is important to remember that though the box might look highly similar, the new Zantac is a different product with a completely different formula. In no way do new sales take away from the harm caused by the original Zantac product, and the legal cases are still very much in progress. 

If you took Zantac and received a cancer diagnosis, you should not let new Zantac sales deter you from seeking help right away. The right Chicago Zantac attorney can help evaluate whether you should join in the Zantac litigation and represent you every step of the way.

You Need an Experienced Chicago Zantac Lawyer On Your Side

At Malman Law, we are taking on Sanofi on behalf of clients injured by Zantac, and we are ready to help you and your family. Call (312) 629-0099 or contact us online for more information about a possible case.